Published in Clin Cosmet Investig Dermatol on February 10, 2015
Novel Insights on Understanding of Keloid Scar: Article Review. J Am Coll Clin Wound Spec (2016) 0.76
Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet (1995) 2.57
Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med (2001) 2.33
Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev (2006) 2.30
Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J (2005) 2.23
Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann N Y Acad Sci (2008) 1.92
Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol (2006) 1.82
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
The skin immune system: progress in cutaneous biology. Immunol Today (1993) 1.76
Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72
Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol (2013) 1.71
Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg (2007) 1.70
Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci (1996) 1.70
Cytokine modulation of keratinocyte cytokines. J Invest Dermatol (1990) 1.59
Intralesional botulinum toxin type A injection as a new treatment measure for keloids. Plast Reconstr Surg (2009) 1.59
Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol (2005) 1.58
Neuronal plasticity of the "brain-skin connection": stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. J Mol Med (Berl) (2007) 1.58
Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab (2002) 1.46
Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology (2003) 1.46
Keloids: A viral hypothesis. Med Hypotheses (2007) 1.40
Genetics of keloid scarring. Arch Dermatol Res (2010) 1.27
Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol (2004) 1.24
Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab (2007) 1.20
The immune system as the sixth sense. J Intern Med (2005) 1.14
A short history of sweat gland biology. Int J Cosmet Sci (2007) 1.12
Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis. PLoS One (2009) 1.12
Cutaneous innervation and itch in keloids. Acta Derm Venereol (2012) 1.10
Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol (2007) 1.08
Hypertrophic response and keloid diathesis: two very different forms of scar. Plast Reconstr Surg (2005) 1.07
From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation (2007) 1.07
Altered cytokine production in black patients with keloids. J Clin Immunol (1992) 1.07
Mechanobiology of scarring. Wound Repair Regen (2011) 1.04
Coexpression of cholinergic and noradrenergic phenotypes in human and nonhuman autonomic nervous system. J Comp Neurol (2005) 1.03
Psychological stress and immunoprotection versus immunopathology in the skin. Clin Dermatol (2012) 1.01
Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair Regen (2000) 1.00
Upregulation of TGF-beta1 expression may be necessary but is not sufficient for excessive scarring. J Invest Dermatol (2006) 0.99
Human skin: an independent peripheral endocrine organ. Horm Res (2000) 0.99
In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J (2001) 0.98
Hair-cycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. J Invest Dermatol (2001) 0.97
Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. J Clin Endocrinol Metab (2000) 0.96
Management of keloids and hypertrophic scars: current and emerging options. Clin Cosmet Investig Dermatol (2013) 0.95
Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings. Int Wound J (2012) 0.94
Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle-dependent expression, and induce catagen. Am J Pathol (2003) 0.92
Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res (1997) 0.92
Sympathetic denervation impairs epidermal healing in cutaneous wounds. Wound Repair Regen (2000) 0.91
Stress and psychoneuroimmunologic factors in dermatology. Dermatol Clin (2005) 0.91
Effect of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts. Front Biosci (1998) 0.91
Effects of various growth factors and histamine on cultured keloid fibroblasts. Dermatology (1995) 0.91
Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res (2005) 0.90
Does psychosocial stress predict symptomatic herpes simplex virus recurrence? A meta-analytic investigation on prospective studies. Brain Behav Immun (2009) 0.90
Prolactin--a novel neuroendocrine regulator of human keratin expression in situ. FASEB J (2010) 0.89
Study of psychological stress, sebum production and acne vulgaris in adolescents. Acta Derm Venereol (2007) 0.89
Keloid scarring: understanding the genetic basis, advances, and prospects. Arch Plast Surg (2012) 0.88
Silicone gel sheets relieve pain and pruritus with clinical improvement of keloid: possible target of mast cells. J Dermatolog Treat (2003) 0.88
Keloid and hypertrophic scar: neurogenic inflammation hypotheses. Med Hypotheses (2008) 0.87
Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates. Acta Derm Venereol (2012) 0.86
Role of mast cells and sensory nerves in skin inflammation. G Ital Dermatol Venereol (2010) 0.86
Epidermal cytokines. Acta Derm Venereol Suppl (Stockh) (1989) 0.85
Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis. Dermatol Res Pract (2012) 0.85
Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation (Review). Biomed Rep (2013) 0.84
Mast cells and myofibroblasts in keloid: a light microscopic, immunohistochemical and ultrastructural study. Ann Acad Med Singapore (1995) 0.84
Innervation of normal and hypertrophic human scars and experimental wounds in the rat. Ann Chir Gynaecol (2001) 0.84
The keloid phenomenon: progress toward a solution. Clin Anat (2007) 0.84
High-fat diet exacerbates inflammation and cell survival signals in the skin of ultraviolet B-irradiated C57BL/6 mice. Toxicol Appl Pharmacol (2009) 0.84
Immunohistochemical expression of TGF-β1 in keloids and hypertrophic scars. Am J Dermatopathol (2011) 0.83
Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab (2010) 0.82
Stress, the neuroendocrine system and mast cells: current understanding of their role in psoriasis. Expert Rev Clin Immunol (2012) 0.82
Mechanical receptor-related mechanisms in scar management: a review and hypothesis. Plast Reconstr Surg (2010) 0.82
Mechanobiological dysregulation of the epidermis and dermis in skin disorders and in degeneration. J Cell Mol Med (2013) 0.81
Effect of ultraviolet light on the release of neuropeptides and neuroendocrine hormones in the skin: mediators of photodermatitis and cutaneous inflammation. J Investig Dermatol Symp Proc (1999) 0.81
Pathological niche environment transforms dermal stem cells to keloid stem cells: a hypothesis of keloid formation and development. Med Hypotheses (2013) 0.81
Essential role of IL-6 signaling pathway in keloid pathogenesis. J Nippon Med Sch (2007) 0.81
Keloid scars and treatment with Botulinum Toxin Type A: the Belfast experience. J Plast Reconstr Aesthet Surg (2012) 0.80
[The sebaceous gland]. Hautarzt (2010) 0.80
Cell talk: a phenomenon observed in the keloid scar by immunohistochemical study. Appl Immunohistochem Mol Morphol (2011) 0.80
Eradication of keloids: Surgical excision followed by a single injection of intralesional 5-fluorouracil and botulinum toxin. Can J Plast Surg (2013) 0.80
Neuropeptides: role in inflammatory skin diseases. J Eur Acad Dermatol Venereol (1998) 0.79
Treatment of a painful keloid with botulinum toxin type A. Am J Phys Med Rehabil (2010) 0.79
Potential role of neurogenic inflammatory factors in the pathogenesis of vitiligo. J Cutan Med Surg (2012) 0.79
Neuropeptide-containing nerves in painful hypertrophic human scar tissue. Br J Dermatol (1994) 0.79
Psychological stress as a risk factor for postoperative keloid recurrence. J Psychosom Res (2012) 0.78
[Stress and seborrheic dermatitis]. Ann Dermatol Venereol (2007) 0.78
Keloid heterograft in the hamster (Mesocricetus auratus) cheek pouch, Brazil. Acta Cir Bras (2005) 0.78
Propiomelanocortin (POMC) gene expression by normal skin and keloid fibroblasts in culture: modulation by cytokines. Exp Dermatol (1997) 0.77
Psychoneuroimmunologic aspects of skin diseases. Acta Clin Croat (2013) 0.77
Painful hypertrophic scarring and neuropeptides. Lancet (1992) 0.77
IL-6 signaling pathway in keloids: a target for pharmacologic intervention? J Invest Dermatol (2007) 0.77
Control of the skin scarring response. An Acad Bras Cienc (2009) 0.76
Nerve fibres: a possible role in keloid pathogenesis. Br J Dermatol (2008) 0.76
What factors affect the quality of life of patients with keloids? Rev Assoc Med Bras (2010) 0.76
[Neurotization and innervation of the human scar-keloids]. Z Haut Geschlechtskr (1969) 0.75
Keloids: a new challenge for nutrition. Nutr Rev (2010) 0.75
About strawberry, crab claws, and the Sir James Black's invention. Hypothesis: can we battle keloids with propranolol? Med Hypotheses (2009) 0.75